Novartis to Acquire Myricx Bio for Up to $1.5 Billion to Bolster Next-Gen ADC Pipeline
Novartis is gaining B7-H3 and HER2 ADCs with innovative NMTi technology designed to overcome cancer resistance.
Novartis is gaining B7-H3 and HER2 ADCs with innovative NMTi technology designed to overcome cancer resistance.
Following multiple bids, the board now backs the offer amid rising shares and challenging market conditions.
Uber has halted planned Uber Eats launches in five European markets just months after announcing them, as it intensifies its pursuit of rival Delivery Hero in a potential €10 billion takeover.
The Board will form a Special Committee to evaluate the offer.
The move would significantly boost its naval sonar, sonobuoy, and torpedo defense portfolio.
Strong production outlook helps Apple navigate global memory chip shortage.